We then tested the combination of E7107 and a CHEK2 inhibitor (BML277) (72, 73) in T-ALL cell lines and found high synergy scores between the two compounds (Fig. 5G). The gene discussed is CHEK2; the disease is acute lymphoblastic leukemia.